Interleukin-2 therapy does not exacerbate multiple sclerosis.
van Oosten
B W
BW
Department of Neurology, Free University Hospital, Amsterdam, The Netherlands.
Uitdehaag
B M
BM
Barkhof
F
F
Hartung
H P
HP
Wagstaff
J
J
Polman
C H
CH
D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology*
D007376:Interleukin-2